Javier Garciá Corbacho

Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1–Deficient Thoracic Cancers

Emma Beddowes, James Spicer, Pui Ying Chan et al. · Journal of Clinical Oncology · 2017 · 122 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer

R. Charles Coombes, P. D. Badman, X. Liu et al. · Nature Communications · 2022 · 67 citations · Full text

Medicine, Oncology, Pharmacology +16

Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies

Melissa L. Johnson, Anthony B. El-Khoueiry, Navid Hafez et al. · Clinical Cancer Research · 2021 · 62 citations · Full text

Medicine, Oncology, Pharmacology +17

Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study

Javier Garciá Corbacho, Alberto Indacochea, Azucena E. González Navarro et al. · Cancer Immunology Immunotherapy · 2023 · 19 citations · Full text

Medicine, Immunology, Oncology +17

Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumours

James Spicer, Richard D. Baird, Aneta Suder et al. · European Journal of Cancer · 2014 · 15 citations · Full text

Medicine, Oncology, Pharmacology +13